Table 11.
References, GEO Accesion, Health Status, Origin of Study, AML subtypes of the study and Overall Survival of the train and validation set of 2177 individuals. The index corresponds to the index of Table 7. Some references which have not been published yet are notated with NYP.
| Index | Reference | GEO Acc. | AML/Healthy | City, Country, Org. | AML subtypes | OS |
|---|---|---|---|---|---|---|
| 0 | [19] | GSE10258 | AML | Vienna, Austria, Medical University of Vienna | M1, M5 | n/a |
| 1 | [20], [21] | GSE10358 | AML | St Louis, USA, Washington University School of Medicine | M0, M1, | n/a |
| M2, M3, | ||||||
| M4, M5, | ||||||
| M6, M7 | ||||||
| 2 | [22] | GSE11375 | Healthy | Boston, USA, Massachusetts General Hospital | n/a | n/a |
| 3 | [23], [24] | GSE12417 | AML | Munich, Germany, University of Munich | M0, M1, | Mean: 614.76, |
| M2, M4, | Std: 503.59 | |||||
| M5, M6 | ||||||
| 4 | [25], [26], [27] | GSE14468 | AML | Houston, USA, MD Anderson Cancer Center | M0, M1, | n/a |
| M2, M3, | ||||||
| M4, M4 eos, | ||||||
| M5, M6 | ||||||
| 5 | [28] | GSE14479 | AML | Rotterdam, Netherlands, Erasmus University Medical Center | n/a | n/a |
| 6 | [29] | GSE15434 | AML | New York, USA, Columbia University Medical Center | n/a | n/a |
| 7 | Wu 2012 (NYP) | GSE15932 | Healthy | Hangzhou, China, Second Affiliated Hospital, School of Medicine, Zhejiang University | n/a | n/a |
| 8 | [30] | GSE16028 | Healthy | Basel, Switzerland, F.Hoffmannn/La Roche AG | n/a | n/a |
| 9 | Krug 2011 (NYP) | GSE17114 | Healthy | Lisbon, Portugal, Instituto de Medicina Molecular | n/a | n/a |
| 10 | [31] | GSE18123 | Healthy | Boston, USA, Boston Children's Hospital | n/a | n/a |
| 11 | [32] | GSE18781 | Healthy | Portland, USA, Oregon Health & Science University | n/a | n/a |
| 12 | [33] | GSE19743 | Healthy | Palo Alto, USA, Stanford Genome Technology Center | n/a | n/a |
| 13 | [34] | GSE23025 | AML | Duarte, USA, City of Hope Beckman Research Institute | n/a | n/a |
| 14 | [35] | GSE25414 | Healthy | Barcelona, Spain, Institut de Recerca Hospital Vall d'Hebron | n/a | n/a |
| 15 | [36] | GSE2842 | Healthy | Bolzano, Italy, EURAC | n/a | n/a |
| 16 | [37] | GSE29883 | AML | Berlin, Germany, Charité | t(8;21), t(16;16) | n/a |
| 17 | [38] | GSE36809 | Healthy | Boston, USA, Massachusetts General Hospital | n/a | n/a |
| 18 | [39], [40], [41], [42] | GSE37642 | AML | Munich, Germany, University Hospital Grosshadern, Ludwign/Maximiliansn/University (LMU) | M0, M1, | Mean: 962.32, |
| M2, M3, | Std: 1106.70 | |||||
| M4, M5, | ||||||
| M6, M7 | ||||||
| 19 | [43], [44] | GSE39088 | Healthy | Brussels, Belgium, Université catholique de Louvain | n/a | n/a |
| 20 | Bullinger 2014 (NYP) | GSE39363 | AML | Berlin, Germany, Charité | t(3;3) | n/a |
| 21 | [45] | GSE46449 | Healthy | New York, USA, Columbia University Medical Center | n/a | n/a |
| 22 | [46], [47] | GSE46819 | AML | Berlin, Germany, Charité | t(16;16) | n/a |
| 23 | Leong 2015 (NYP) | GSE68833 | AML | Rockville, USA, NCI | M0, M1, | n/a |
| M2, M3, | ||||||
| M4, M5, | ||||||
| M6, M7 | ||||||
| 24 | [48] | GSE69565 | AML | Singapore, Singapore, Cancer Science Institute of Singapore | n/a | n/a |
| 25 | Meng 2015 (NYP) | GSE71226 | Healthy | Changchun, China, the Department of Cardiology, China-Japan Union Hospital, Jilin University | n/a | n/a |
| 26 | Bohl 2016 (NYP) | GSE84334 | AML | Ulm, Germany, University Hospital of Ulm | n/a | n/a |
| 27 | [49] | GSE84844 | Healthy | Fujisawa, Japan, Takeda Pharmaceutical Company Limited | n/a | n/a |
| 28 | [50] | GSE93272 | Healthy | Fujisawa, Japan, Takeda Pharmaceutical Company Limited | n/a | n/a |
| 29 | [51] | GSE98793 | Healthy | Cambridge, United Kingdom, University of Cambridge | n/a | n/a |
| 30 | [52] | GSE99039 | Healthy | Tel Aviv, Israel, Tel Aviv University | n/a | n/a |
| 31 | Green 2009 (NYP) | GSE14845 | Healthy | Southport, Australia, Griffith Insitute for Health & Medical Research | n/a | n/a |